Phase 1/2 Study of Donor-Derived Anti-CD33 Chimeric Antigen Receptor Expressing T Cells (VCAR33) in Patients with Relapsed or Refractory Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation

被引：6

作者：

Shah, Nirali N. ^{[1
]}

Azzi, Jacques ^{[2
]}

Cooper, Brenda W. ^{[3
]}

Deol, Abhinav ^{[4
]}

DiPersio, John ^{[5
]}

Koura, Divya ^{[6
]}

McClune, Brian ^{[7
]}

Muffly, Lori S. ^{[8
]}

Mushtaq, Muhammad Umair ^{[9
]}

Narayan, Rupa ^{[10
]}

Suh, Hyung Chan ^{[11
]}

Yanik, Gregory ^{[12
]}

Nath, Sritama ^{[13
]}

Whangbo, Jennifer ^{[13
]}

Koehne, Guenther ^{[14
]}

机构：

[1] Natl Inst Hlth, Pediat Oncol Branch, Bethesda, MD USA

[2] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol Cellular Therapy & Bone M, Tisch Canc Inst, New York, NY USA

[3] Univ Hosp Seidman Canc Ctr, Cleveland, OH USA

[4] Wayne State Univ, Karmanos Canc Inst, Dept Oncol, Detroit, MI USA

[5] Washington Univ, Dept Internal Med, Div Oncol, St Louis, MO USA

[6] UCSD Moores Canc Ctr, La Jolla, CA USA

[7] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[8] Stanford Univ, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USA

[9] Univ Kansas, Div Hematol Malignancies & Cellular Therapeut, Med Ctr, Westwood, KS USA

[10] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA USA

[11] Hackensack Univ, Med Ctr, Hackensack, NJ USA

[12] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA

[13] Vor Biopharma, Cambridge, MA USA

[14] Miami Canc Inst, Baptist Hlth South Florida, Miami, FL USA

来源：

关键词：

D O I：

10.1182/blood-2023-180990

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4